Table 2 Baseline Characteristics; Medication
From: Obesity – a risk factor for postoperative complications in general surgery?
Normal weight | Underweight | Overweight | Obese | p value | |
|---|---|---|---|---|---|
BMI 18.5–25(kg/m2) | BMI < 18.5(kg/m2) | BMI 25–30(kg/m2) | BMI > 30(kg/m2) | ||
(N = 1815) | (N = 100) | (N = 1635) | (N = 743) | ||
Medication groups | |||||
Antiplatelet therapy | 214 (11.8 %) | 12 (12.0 %) | 247 (15.1 %)a | 122 (16.4 %)a | 0.005 |
Anticoagulant therapy | 59 (3.3 %) | 5 (5.0 %) | 62 (3.8 %) | 35 (4.7 %) | 0.31 |
ßblockers | 165 (9.1 %) | 13 (13.0 %) | 225 (13.8 %)a | 116 (15.6 %)a | <0.001 |
Calcium channel blockers | 66 (3.6 %) | 2 (2.0 %) | 80 (4.9 %)a | 58 (7.8 %)a | <0.001 |
Angiotensin-converting enzyme inhibitors | 103 (5.7 %) | 4 (4.0 %) | 123 (7.5 %)a | 78 (10.5 %)a | <0.001 |
Angiotensin-II receptor antagonists | 58 (3.2 %) | 1 (1.0 %) | 118 (7.2 %)a | 72 (9.7 %)a | <0.001 |
Statins | 195 (10.7 %) | 10 (10.0 %) | 238 (14.6 %)a | 141 (19.0 %)a | <0.001 |
Diuretics | 199 (11.0 %) | 13 (13.0 %) | 252 (15.4 %)a | 147 (19.8 %)a | <0.001 |
Nitrates | 90 (5.0 %) | 3 (3.0 %) | 119 (7.3 %)a | 42 (5.7 %) | 0.018 |
Pulmonary medication | 86 (4.7 %) | 4 (4.0 %) | 71 (4.3 %) | 48 (6.5 %) | 0.153 |